Effectiveness of the Risk Stratification Proposed by the 2022 European Heart Rhythm Association Expert Consensus Statement on Arrhythmic Mitral Valve Prolapse.

[1]  B. Vandenberk,et al.  Sex and racial disparities in catheter ablation , 2022, Heart rhythm O2.

[2]  Francesca N. Delling,et al.  Research Opportunities in the Treatment of Mitral Valve Prolapse , 2022, Journal of the American College of Cardiology.

[3]  T. Helle-Valle,et al.  Ventricular arrhythmias in arrhythmic mitral valve syndrome—a prospective continuous long-term cardiac monitoring study , 2022, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  D. Andreini,et al.  Myocardial Fibrosis at Cardiac MRI Helps Predict Adverse Clinical Outcome in Patients with Mitral Valve Prolapse. , 2022, Radiology.

[5]  B. Gersh,et al.  CHARACTERIZATION OF VENTRICULAR ARRHYTHMIAS AND SUDDEN CARDIAC DEATH IN SUBJECTS WITH MITRAL VALVE PROLAPSE AND MITRAL ANNULAR DISJUNCTION. , 2022, Heart rhythm.

[6]  G. Mairesse,et al.  Inequality between women and men in ICD implantation , 2022, International journal of cardiology. Heart & vasculature.

[7]  I. Tonhajzerova,et al.  Complex sympathetic regulation in adolescent mitral valve prolapse. , 2021, Physiological research.

[8]  J. Bogaert,et al.  Left ventricular remodelling in mitral valve prolapse patients: implications of apical papillary muscle insertion. , 2021, European heart journal. Cardiovascular Imaging.

[9]  H. Michelena,et al.  The Mitral Annular Disjunction of Mitral Valve Prolapse: Presentation and Outcome. , 2021, JACC. Cardiovascular imaging.

[10]  W. Zareba,et al.  Survival After Implantable Cardioverter-Defibrillator Shocks. , 2021, Journal of the American College of Cardiology.

[11]  H. Michelena,et al.  Presentation and Outcome of Arrhythmic Mitral Valve Prolapse. , 2020, Journal of the American College of Cardiology.

[12]  T. Dewland,et al.  Primary Prevention ICDs in Nonischemic Cardiomyopathy: Time to Put the Toothpaste Back in the Tube? , 2020, Journal of the American College of Cardiology.

[13]  S. Iliceto,et al.  Mitral Valve Prolapse, Ventricular Arrhythmias, and Sudden Death. , 2019, Circulation.

[14]  M. Sheppard,et al.  Mitral valve and left ventricular features in malignant mitral valve prolapse , 2018, Open Heart.

[15]  T. Helle-Valle,et al.  The Mitral Annulus Disjunction Arrhythmic Syndrome. , 2018, Journal of the American College of Cardiology.

[16]  A. Brandes,et al.  Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure , 2017, Circulation.

[17]  Yuchi Han,et al.  Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[18]  J. Ector,et al.  Changes in Implantation Patterns and Therapy Rates of Implantable Cardioverter Defibrillators over Time in Ischemic and Dilated Cardiomyopathy Patients , 2016, Pacing and clinical electrophysiology : PACE.

[19]  Jagmeet P. Singh,et al.  2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[20]  Sabino Iliceto,et al.  Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death , 2015, Circulation.

[21]  J. Goldberger,et al.  Sudden cardiac death risk stratification. , 2015, Circulation research.

[22]  Martin Borggrefe,et al.  [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy]. , 2014, Kardiologia polska.

[23]  Dudley J Pennell,et al.  Reference left atrial dimensions and volumes by steady state free precession cardiovascular magnetic resonance , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[24]  M. Brignole.  Are complications of implantable defibrillators under-estimated and benefits over-estimated? , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[25]  M. Josephson,et al.  A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. , 2008, Journal of the American College of Cardiology.

[26]  M. Das,et al.  Significance of a Fragmented QRS Complex Versus a Q Wave in Patients With Coronary Artery Disease , 2006, Circulation.

[27]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Circulation.

[28]  R A Levine,et al.  Prevalence and clinical outcome of mitral-valve prolapse. , 1999, The New England journal of medicine.

[29]  T. N. James,et al.  Dysautonomia in mitral valve prolapse. , 1979, The American journal of medicine.

[30]  X. Ye,et al.  A novel role of sympathetic activity in regulating mitral valve prolapse. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[31]  N. Rofsky,et al.  Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.